Summary
70 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 28% a year over the last 3 years.
- Out of every 100 INR of revenue, 15 INR is left as net profit.
- It earns 14 INR a year on every 100 INR of invested capital.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 32.4 INR for 1 INR of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (INR)
Diluted EPS (INR)
Revenue grew by 18% a year over 5 years. Over the last 3 years it grew by 16% a year. Earnings per share grew by 28% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 INR of revenue goes
- Cost of sales 55 INR
- Sales and administration 25 INR
- Taxes and other 5.5 INR
- Net profit 15 INR
Net profit, industry median (Medical - Care Facilities) 6.8 INR
Out of every 100 INR of revenue, 15 INR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenIts debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 0.25%
- Paid out of profit
- 8.1%
You receive ₹15.00 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail